Preliminary Program
Stream 3: New Modalities of Medicinal Chemistry
Session 301: New Small Molecule Drug Discovery
Time: 08:30-12:00, November 16, 2019 (Saturday)
Place: Nanjing, China
Chair: Dr.Yonghui Wang, Professor, Fudan University, China
Co-Chair: Call for Co-chair
Time |
FaceOn |
Speeches and Speakers |
08:30-08:35 |
Chair's Introduction |
|
08:35-09:00 |
|
Title: |
09:00-09:25 |
|
Dr. Andreas Goutopoulos, Director, EMD Serono, Inc., USA |
09:25-09:50 |
|
Dr. Yonghui Wang, Professor, Fudan University, China
|
09:50-10:15 |
|
Title: |
10:15-10:30 |
Coffee Break |
Session 302: Natural Products and Macrocycles in Medicinal Chemistry
Time: 13:30-17:30, November 16, 2019 (Saturday)
Place: Nanjing, China
Chair: Call for Chair
Co-Chair: Call for Co-chair
Time |
FaceOn |
Speeches and Speakers |
13:30-13:35 |
Chair's Introduction |
|
13:35-14:00 |
|
Title: Discovery and Development of Eribulin, a Macrocyclic Ketone Analog of Marine Sponge Natural Product Halichondrin B |
14:00-14:25 |
|
Dr. Steven King, Senior Vice President, Napo Pharmaceuticals, USA |
14:25-14:50 |
|
Dr. Paul Hanson, Professor, University of Kansas, USA |
14:50-15:15 |
|
Title: |
15:15-15:30 |
Coffee Break |
Session 303: Macromolecular Medicinal Chemistry
Time: 08:30-12:00, November 17, 2019 (Sunday)
Place: Nanjing, China
Chair: Dr. Jiren Zhang, Oncology Center, ZhuJiang Hospital of Southern Medical University, China
Co-Chair: Call for Co-chair
Time |
FaceOn |
Speeches and Speakers |
08:30-08:35 |
Chair's Introduction |
|
08:35-09:00 |
|
Dr. Suresh Srivastava, President & CEO, ChemGenes Corp., USA |
09:00-09:25 |
|
Dr. Ali Fallah, CEO, RNAx Ltd., UK |
09:25-09:50 |
|
Dr. Kirill Kalnin, Head Biologic Design, Sanofi Pasteur, USA |
09:50-10:15 |
![]() |
Title: Molecular Mechanism Study of Vitorgan Cell Molecular Therapy |
10:15-10:30 |
Coffee Break |
|
10:30-10:55 |
![]() |
Dr. Joseph Frank, Senior Investigator, National Institutes of Health, USA |
10:55-11:20 |
![]() |
Title: |
11:20-11:45 |
![]() |
Title: |